BRPI0508615A - lingandos de bisfosfina c1-simétrica e seu emprego na sìntese assimétrica de pregabalina - Google Patents

lingandos de bisfosfina c1-simétrica e seu emprego na sìntese assimétrica de pregabalina

Info

Publication number
BRPI0508615A
BRPI0508615A BRPI0508615-9A BRPI0508615A BRPI0508615A BR PI0508615 A BRPI0508615 A BR PI0508615A BR PI0508615 A BRPI0508615 A BR PI0508615A BR PI0508615 A BRPI0508615 A BR PI0508615A
Authority
BR
Brazil
Prior art keywords
asymmetric
synthesis
pregabalin
symmetric bisphosphine
bisphosphine ligands
Prior art date
Application number
BRPI0508615-9A
Other languages
English (en)
Inventor
Jian Bao
Vladimir Genukh Beylin
Derek Joseph Greene
Garrett Hoge
William Kissel
Mark Eugene Marlatt
Derek Andrew Pflum
He-Ping Wu
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961258&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0508615(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BRPI0508615A publication Critical patent/BRPI0508615A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5027—Polyphosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5045—Complexes or chelates of phosphines with metallic compounds or metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5329—Polyphosphine oxides or thioxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5463—Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/822—Rhodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

LIGANDOS DE BISFOSFINA C~ 1~-SIMéTRICA E SEU EMPREGO NA SìNTESE ASSIMéTRICA DE PREGABALINA. A presente invenção refere-se a materiais e métodos para a preparação de ácido (S)-(+)-3-(aminometil)-5-metil-hexanóico e compostos relacionados estruturamente por meio de hidrogenação enantiosseletiva de olefinas pró-quirais são descritos. Os métodos empregam novos catalisadores quirais, que incluem ligando de bisfosfina C~ 1~-simétrica ligados a metais de transição.
BRPI0508615-9A 2004-03-12 2005-03-09 lingandos de bisfosfina c1-simétrica e seu emprego na sìntese assimétrica de pregabalina BRPI0508615A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55258604P 2004-03-12 2004-03-12
US58651204P 2004-07-09 2004-07-09
PCT/IB2005/000642 WO2005087370A1 (en) 2004-03-12 2005-03-09 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin

Publications (1)

Publication Number Publication Date
BRPI0508615A true BRPI0508615A (pt) 2007-07-31

Family

ID=34961258

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508615-9A BRPI0508615A (pt) 2004-03-12 2005-03-09 lingandos de bisfosfina c1-simétrica e seu emprego na sìntese assimétrica de pregabalina

Country Status (21)

Country Link
US (2) US20050228190A1 (pt)
EP (1) EP1727620B1 (pt)
JP (1) JP2007528893A (pt)
KR (2) KR100847922B1 (pt)
AR (1) AR051533A1 (pt)
AT (1) ATE371496T1 (pt)
AU (1) AU2005221401A1 (pt)
BR (1) BRPI0508615A (pt)
CA (1) CA2559086A1 (pt)
CY (1) CY1106877T1 (pt)
DE (1) DE602005002253T2 (pt)
DK (1) DK1727620T3 (pt)
ES (1) ES2292107T3 (pt)
IL (1) IL177482A0 (pt)
NO (1) NO20063574L (pt)
NZ (1) NZ549004A (pt)
PL (1) PL1727620T3 (pt)
PT (1) PT1727620E (pt)
RU (1) RU2335342C2 (pt)
TW (1) TWI299990B (pt)
WO (1) WO2005087370A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US7417165B2 (en) 2005-04-06 2008-08-26 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
WO2006110783A2 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
WO2006122259A1 (en) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
KR100893312B1 (ko) * 2005-05-10 2009-04-15 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린 및 이의 염의 제조 방법
KR20070067077A (ko) 2005-05-10 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이소부틸글루타르산을 함유하지 않는 프레가발린 및 이의제조 방법
WO2007035890A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
WO2007127309A2 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 3-isobutylglutaric acid
WO2007139933A2 (en) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
US20080015385A1 (en) * 2006-05-31 2008-01-17 Lilach Hedvati Preparation of (S)-pregabalin-nitrile
EP2071032A3 (en) * 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd The use of enzymatic resolution for the preparation of intermediates of pregabalin
GB0700622D0 (en) * 2007-01-12 2007-02-21 Johnson Matthey Plc Process for preparing cationic rhodium complexes
WO2008118427A2 (en) * 2007-03-22 2008-10-02 Teva Pharmaceutical Industries Ltd. Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
KR20110025917A (ko) 2008-05-21 2011-03-14 산도즈 아게 ５－메틸－３－니트로메틸－헥산산 에스테르의 입체선택적 효소 가수분해 방법
US20100087525A1 (en) * 2008-06-23 2010-04-08 Lilach Hedvati Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
GB0812290D0 (en) * 2008-07-04 2008-08-13 Johnson Matthey Plc Process for preparing cationic rhodium complexes
JP5750449B2 (ja) 2009-11-05 2015-07-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規キラルリンリガンド
US20120309997A1 (en) 2010-02-12 2012-12-06 Enantia, S.L. Enantiomerically Enriched Aminodiphosphines as Ligands for the Preparation of Catalysts for Asymmetric Synthesis
GB201103092D0 (en) * 2011-02-23 2011-04-06 Univ Dublin Process
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
US10196413B2 (en) 2016-12-06 2019-02-05 Boehringer Ingelheim International Gmbh Chiral dihydrobenzoazaphosphole ligands and synthesis thereof
EP3551638A2 (en) 2016-12-06 2019-10-16 Boehringer Ingelheim International GmbH Novel chiral dihydrobenzooxaphosphole ligands and synthesis thereof
JP6949903B2 (ja) 2019-06-24 2021-10-13 日本化学工業株式会社 光学活性ビスホスフィノメタン及びその製造方法、並びに遷移金属錯体及び不斉触媒
CN111647020A (zh) * 2020-04-09 2020-09-11 宁波赜军医药科技有限公司 一种膦氧双齿配体的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
US6194459B1 (en) * 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
JP2002520286A (ja) * 1998-07-09 2002-07-09 ワーナー−ランバート・カンパニー Ｇａｂａ類縁体及びカフェインを含んでなる組成物
US6306910B1 (en) * 1998-07-09 2001-10-23 Warner-Lambert Company Use of Gaba-analogues for treating insomnia
KR100697734B1 (ko) * 1998-10-16 2007-03-22 워너-램버트 캄파니 엘엘씨 조증 및 양극성 장애 치료용 제약 조성물
SI1250311T1 (en) * 2000-01-27 2004-10-31 Warner-Lambert Company Asymmetric synthesis of pregabalin
MXPA02001147A (es) * 2001-03-19 2004-04-21 Warner Lambert Co Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica.
US6696058B2 (en) * 2002-01-29 2004-02-24 Laclede, Inc. Aqueous enzymatic denture adhesives
NI200300043A (es) * 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.

Also Published As

Publication number Publication date
KR20070074671A (ko) 2007-07-12
JP2007528893A (ja) 2007-10-18
WO2005087370A1 (en) 2005-09-22
DE602005002253D1 (de) 2007-10-11
RU2006132505A (ru) 2008-03-27
KR20060118603A (ko) 2006-11-23
NO20063574L (no) 2006-09-05
CY1106877T1 (el) 2012-09-26
KR100823758B1 (ko) 2008-04-21
ES2292107T3 (es) 2008-03-01
NZ549004A (en) 2009-04-30
IL177482A0 (en) 2006-12-10
KR100847922B1 (ko) 2008-07-22
RU2335342C2 (ru) 2008-10-10
AR051533A1 (es) 2007-01-24
AU2005221401A1 (en) 2005-09-22
CA2559086A1 (en) 2005-09-22
TW200600090A (en) 2006-01-01
US20050228190A1 (en) 2005-10-13
DK1727620T3 (da) 2007-12-03
PL1727620T3 (pl) 2007-12-31
DE602005002253T2 (de) 2008-05-29
PT1727620E (pt) 2007-11-05
US20090124820A1 (en) 2009-05-14
TWI299990B (en) 2008-08-21
EP1727620B1 (en) 2007-08-29
EP1727620A1 (en) 2006-12-06
ATE371496T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
TW200600090A (en) C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
Noyori Asymmetric catalysis: science and opportunities (Nobel Lecture 2001)
Toru et al. Organosulfur chemistry in asymmetric synthesis
Pelagatti et al. Transfer hydrogenation of acetophenone catalyzed by half-sandwich ruthenium (II) complexes containing amino amide ligands. Detection of the catalytic intermediates by electrospray ionization mass spectrometry
Bonini et al. A critical outlook and comparison of enantioselective oxidation methodologies of olefins
NL1015655C2 (nl) Katalysator voor de asymmetrische hydrogenering.
de Parrodi et al. Chiral 1, 2-amino alcohols and 1, 2-diamines derived from cyclohexene oxide: recent applications in asymmetric synthesis
TW200510273A (en) Process to chiral beta amino acid derivatives by asymmetric hydrogenation
AR052879A1 (es) Procedimiento para preparar derivados de beta aminoacidos quirales por hidrogenacion asimetrica
CL2011000450A1 (es) Proceso para preparar una composicion farmaceutica que comprende a) mezclar un agonista del receptor s1p, seleccionado de 2-amino-2-[2-(4-octilfenil)etil]propano-1,3-diol y una sal del mismo, con un alcohol de azucar; b) moler y/o granular la mezcla; y c) mezclar la mezcla con un lubricante (divisional solicitud 745-2004).
GT200200100AA (es) Resolucion de sal quiral(solicitud fraccionaria no.1 derivada de la patente pi-2002-0100).
WO2004076464A3 (en) Optically active phosphites and phosphoramidites and their use in asymmetric reactions
BR9812207A (pt) Catalisador, processos para preparar um catalisador, misturas de mononitrilas c5 monoolefìnicas e adiponitrila, e, uso de catalisadores
DE502005011299D1 (de) Verfahren zur herstellung von linearem pentennitril
BR0307120A (pt) Processo para a preparação de compostos sin-1-(4-hidróxil-fenil)-2-(4-hidróxi-4-fenil-piperidin-1-i l)-1-propanol não-racêmico.
WO2007021858A3 (en) Methods of making radiolabeled tracers and precursors thereof
BRPI0718351A2 (pt) "processo para a preparação do enantiômero s ou r, processo para formar um composto r ou s, uso de um catalisador quiral, composto, sal tartrato do enantiômero s ou r de um composto, complexo de metal de transição e catalisador"
Scholtes et al. Supramolecular interlocked biphenyl ligands for enantioselective Ti-catalyzed alkylation of aromatic aldehydes
ATE367372T1 (de) Verfahren zur herstellung von (r)-salbutamol
Salomó et al. Efficient Preparation of (S)-and (R)-tert-Butylmethylphosphine–Borane: A Novel Entry to Important P-Stereogenic Ligands
AR048459A1 (es) Procedimiento de hidrogenacion asimetrica
BRPI0906174A2 (pt) Processo para preparar o enantiômero s ou r de um composto, uso de um catalisador quiral, ru(ligante quiral) (acac)2, ru (ligante quiral) (cf3coo)2, sistema catalítico e rh (norbornadieno)2 pf6 (diph-meo- biphep)
Biradar et al. Highly enantioselective conjugate addition of diethylzinc to substituted chalcones catalyzed by Cu (II) complexes of a tridentate P, N, O ligand
Lam et al. Synthesis of P-chirogenic diarylphosphinoacetic acids and their proline derivatives for palladium-catalysed allylic alkylation reactions
DE50112192D1 (de) Chirale monophosphite als liganden für asymmetrische hydrierung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE A 8.6 NA RPI 2099 DE 29/03/2011.